The acquisition adds six investigators and five study coordinators and research personnel to WCCT’s organization. It also gives the company expanded early-phase capabilities in cornea and external disease, uveitis, vitreoretinal diseases, glaucoma, neuro-ophthalmology, oculoplastics and pediatric ophthalmic conditions.
More Articles on Ophthalmology:
Ophthalmologist Dr. Karl Golnik to Serve as JCAHPO’s 22nd President
Mount Auburn Hospital Names Dr. Christopher Robinson Chief of Ophthalmology
Carolina Eye Associates Ophthalmologists Perform 1k Cataract Surgeries with Catalys Laser
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
